Reduced BCL2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel

AIM OF THE STUDY: Cervical cancer is the second most common malignancy in women worldwide. Everolimus displays direct effects on growth and proliferation of cancer cells via inhibition of mammalian target of rapamycin (mTOR) protein, which is known to be associated with drug resistance. In this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Yilmaz, Akin, Alp, Ebru, Onen, H. Ilke, Menevse, Sevda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829746/
https://www.ncbi.nlm.nih.gov/pubmed/27095936
http://dx.doi.org/10.5114/wo.2016.58498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829746/
https://www.ncbi.nlm.nih.gov/pubmed/27095936
http://dx.doi.org/10.5114/wo.2016.58498

Ejemplares similares